Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | ¥2.75B | ¥3.60B | ¥4.20B | ¥3.60B | ¥2.96B | ¥1.35B | ¥670.5M |
| Gross profit | ¥1.65B | ¥2.18B | ¥2.30B | ¥1.81B | ¥1.55B | ¥757.8M | ¥312.3M |
| Research & development | ¥525.0M | ¥732.6M | ¥901.5M | ¥763.4M | ¥619.6M | ¥329.8M | ¥351.0M |
| Operating expenses | ¥2.16B | ¥2.66B | ¥3.37B | ¥3.41B | ¥2.94B | ¥1.36B | ¥1.37B |
| Operating income | −¥507.3M | −¥481.1M | −¥1.07B | −¥1.60B | −¥1.39B | −¥602.9M | −¥1.06B |
| EBITDAderived | −¥488.3M | −¥459.1M | −¥1.05B | −¥1.58B | −¥1.37B | −¥583.3M | −¥1.04B |
| Net income | −¥195.2M | −¥169.0M | −¥839.5M | −¥1.58B | −¥1.30B | −¥517.5M | −¥1.00B |
| Basic EPSper diluted share | -CN¥0.80 | -CN¥0.63 | -CN¥2.82 | -CN¥5.19 | -CN¥6.12 | -CN¥18.36 | -CN¥22.99 |
| Diluted EPSper diluted share | -CN¥0.80 | -CN¥0.63 | -CN¥2.82 | -CN¥5.19 | -CN¥6.12 | -CN¥18.36 | -CN¥22.99 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026Form 4 | Cheng Li-LanDirector | SellClass A ordinary shares | 360 | $2.85 | $1.0K | 33.5K |